ENDOVASCULAR ENGINEERING, INC.

Medtech · Private

Vortex Catheter Technology — a mechanical thrombectomy device for removing blood clots from pulmonary arteries in pulmonary embolism patients

Grants
$298K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
14
5 granted · 9 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Enhanced Suction Thrombectomy in Pulmonary Embolism Using Vortex Catheter Technology$298,197
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1857PZA INNOVATION LLC——
1858Altrix Medical, Inc.——
1859BULLSEYE BIODEVICES, INC.——
1860ENDOVASCULAR ENGINEERING, INC.——
1861PRESAJ, INC.——
1862Saxon Glass Technologies, Inc.——
1863VascuLogic LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 5 granted of 14

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.